Alterations in renal endothelial nitric oxide synthase expression by salt diet in angiotensin type-1a receptor gene knockout mice.
The effects of altered dietary salt intake and/or hydralazine-induced hypotension on renal endothelial nitric oxide synthase (eNOS) expression were determined in angiotensin type-1a receptor gene knockout (At1a-/-) and wild-type (At1a+/+) mice. In At1a-/- mice, the levels of renal cortical eNOS mRNA and protein were 5 times and 3.5 times higher, respectively, in the high-salt (4% NaCl) group than in the low-salt group (0.3% NaCl). Systemic BP of the high-salt group (105 +/- 4.4 mmHg) was significantly higher than that of the low-salt group (77.0 +/- 4.7 mmHg). When hydralazine was administered to the mutant mice fed a high-salt diet, BP was reduced to 72.5 +/- 1.3 mmHg, with decreases in the levels of renal eNOS mRNA and protein expression to about half of those found in nontreated group. Consistent with the results for eNOS mRNA and protein expression, nicotinamide adenine dinucleotide phosphate (NADPH) diaphorase activity and eNOS immunoreactivity localized in the endothelium of the renal vasculature changed parallel with the amount of salt intake. In contrast to mutant mice, At1a+/+ mice did not show any changes in renal eNOS expression during the manipulation of salt intake and/or hydralazine-induced hypotension. These results suggest that At1a receptor-mediated inputs play critical roles in maintaining renal vascular eNOS expression and activity during changes in salt-water balance and systemic BP.
Sato
Keiko
K
Department of Second Internal Medicine, Yokohama City University, Yokohama, Japan.
Kihara
Minoru
M
Hashimoto
Tatsuo
T
Matsushita
Kei
K
Koide
Yu-Ichi
Y
Tamura
Koichi
K
Hirawa
Nobuhito
N
Toya
Yoshiyuki
Y
Fukamizu
Akiyoshi
A
Umemura
Satoshi
S
D000818:Animals; D015153:Blotting, Western; D001835:Body Weight; D006830:Hydralazine / Q000494:pharmacology; D007150:Immunohistochemistry; D007668:Kidney / Q000098:blood supply / Q000201:enzymology*; D051379:Mice; D018345:Mice, Knockout; D008817:Mice, Mutant Strains; D009252:NADPH Dehydrogenase / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000096:biosynthesis*; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III; D012333:RNA, Messenger / Q000378:metabolism; D044140:Receptor, Angiotensin, Type 1 / Q000235:genetics* / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012492:Salts / Q000494:pharmacology; D012965:Sodium Chloride / Q000494:pharmacology
D012333:RNA, Messenger; D044140:Receptor, Angiotensin, Type 1; D012492:Salts; D006830:Hydralazine; D012965:Sodium Chloride; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III; C496315:Nos3 protein, mouse; D009252:NADPH Dehydrogenase